Ans : An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Also called ibritumomab tiuxetan. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer